CrowdStrike's 2025 data shows attackers breach AI systems in 51 seconds. Field CISOs reveal how inference security platforms ...

Microsoft is working on a redesigned Run dialog for Windows 11, but Raycast has just beaten the company with a much better ...

The Reliability Monitor shows system errors, warnings, and informational and critical events that can help you troubleshoot your Windows PC.

Win streak rewards have arrived in Warzone with Season 1 Reloaded, so here’s every camo and how you can unlock each one.

Japanese cybersecurity software firm Trend Micro has patched a critical security flaw in Apex Central (on-premise) that could allow attackers to execute arbitrary code with SYSTEM privileges.

Vince Zampella, best known as the co-creator of the Call of Duty franchise and co-founder of Infinity Ward who went on to co-found Titanfall, Apex Legends, and Star Wars Jedi developer Respawn ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

If 2023 was the year of shock and 2024 was the year of experimentation, 2025 marks the moment the corporate world finally accepted that artificial intelligence is not just a novelty—it is the new ...

Ballad Health's Clinical Council leverages the expertise of physician leaders and frontline clinicians. The new CMO of Ballad Health's Johnson City Medical Center brings a wealth of experience to the ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...